Related Experiment Videos
Progression of coronary and valvular heart disease in patients on dialysis
Insights
Coronary heart disease and valvular heart disease are common in patients with end-stage renal disease, often going undiagnosed without invasive procedures. Valvular heart disease frequency increases with dialysis duration and indicates a poor prognosis.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- End-stage renal disease (ESRD) patients frequently develop coronary heart disease (CHD).
- Valvular heart disease (VHD) prevalence increases with dialysis duration in ESRD patients.
- Both CHD and VHD are often undiagnosed and underestimated in ESRD patients without invasive investigation.
Purpose of the Study:
- To investigate the prevalence and diagnostic challenges of coronary heart disease and valvular heart disease in end-stage renal disease patients.
- To assess the impact of dialysis on the progression of coronary heart disease.
- To determine the prognostic significance of valvular heart disease in end-stage renal disease.
Main Methods:
- Review of existing literature and clinical data on cardiovascular diseases in ESRD patients.
- Analysis of diagnostic methods for coronary heart disease and valvular heart disease in the context of ESRD.
- Evaluation of the relationship between dialysis duration and valvular heart disease incidence.
- Assessment of prognostic indicators in ESRD patients with valvular heart disease.
Main Results:
- Coronary heart disease is highly prevalent in ESRD patients but often not diagnosed without invasive procedures.
- No evidence suggests accelerated coronary heart disease progression due to dialysis.
- Valvular heart disease frequency rises with longer dialysis periods and is frequently underestimated.
- Valvular heart disease presence is associated with a poor prognosis in ESRD patients.
Conclusions:
- Cardiovascular complications, particularly valvular heart disease, are significant concerns in end-stage renal disease management.
- Non-invasive diagnostic methods may underestimate the burden of valvular heart disease in ESRD.
- Early detection and management of valvular heart disease are crucial for improving outcomes in dialysis patients.
Abstract:
Coronary heart disease and end-stage renal disease: Coronary heart disease is frequent in patients with end-stage renal disease. Without invasive procedures coronary heart disease is often not diagnosed in patients with end-stage renal disease. We have no evidence for accelerated progression of coronary heart disease under conditions of dialysis. Valvular heart disease and end-stage renal disease: Valvular heart disease shows an increasing frequency depending on the period of dialysis. Valvular heart disease is often unnoticed and constantly underestimated without invasive investigation. Valvular heart disease often indicates a bad prognosis in our patients with end-stage renal disease.